← Leaderboards
Christopher C. Derenzo
St. Jude Children'S Research Hospital
$1,462,442
Attributed
$2,924,883
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $754.5K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,924,883 · 1
By mechanism
R01$2,924,883 · 1
Top collaborators
- Stephen Gottschalk4 shared
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Michael A Dyer$24,988,379
- Janet Anne Houghton$8,199,871
- Mark Edward Hatley$4,899,188
- Giedre Krenciute$4,894,202
- Victor M Santana$4,139,851
Others in their field
Other Rising Stars on “Clinical Trials”
- Kiran Datta · Leidos Biomedical Research, Inc.$292,634,066
- Angee Greer · Ppd Development Lp$82,531,927
- Jessica Ellis · Technical Resources International, Inc.$46,538,640
- Jessica Holden · Technical Resources International, Inc.$37,843,443
- Suma Babu · Massachusetts General Hospital$36,168,406
- Sabrina Paganoni · Massachusetts General Hospital$36,168,406
Research focus
Clinical TrialsCombined Modality TherapyClinical ResearchAntitumor EffectAdoptive TransferAntigensAntigen TargetingAdultBisulfite SequencingBrain NeoplasmsApplications GrantsCd19 GeneCd276 GeneCd28 GeneCellsCell SurfaceCell TherapyBiopsyChildChildhoodChildhood Solid NeoplasmChimeric Antigen ReceptorChimeric Antigen Receptor T CellsCorrelative Study
Grant awards (4)
Enhancing B7-H3-CAR T cell therapy for pediatric solid tumors$754,519
R01 · FY2025 · CA · contact PI
Enhancing B7-H3-CAR T cell therapy for pediatric solid tumors$716,793
R01 · FY2024 · CA · contact PI
Enhancing B7-H3-CAR T cell therapy for pediatric solid tumors$719,445
R01 · FY2023 · CA · contact PI
Enhancing B7-H3-CAR T cell therapy for pediatric solid tumors$734,126
R01 · FY2022 · CA · contact PI